focus -WSS

focus

author：entertainment 2025-08-26 01:34:12 - browse：7785

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： It's time to get medical device identifiers over the finish line

hotspot

WSS

1 dead, 9 hurt in July 4th fireworks explosion

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

California’s proposed $25 per hour health care minimum wage

Russians and Belarusians back at Wimbledon as war in Ukraine continues

California’s proposed $25 per hour health care minimum wage

Palantir health business leans on meeting customers’ needs

knowledge

focus

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Lecanemab for Alzheimer's is coming. Is the health system ready?

Jerome Adams on the need for new antivirals for Covid

What to know about OceanGate, the company behind the missing Titanic submersible

BioMarin wins approval for gene therapy to treat hemophilia A

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Medicare proposal to cover medical devices draws a mixed reaction

It's time to get medical device identifiers over the finish line

Duchenne breakthrough therapy leaves behind pioneering families

Retired US general questions alleged Putin, Prigozhin meeting

explore

Leqembi, other new Alzheimer’s drugs require better biomarkers

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Iowa House, Senate pass 6

Leqembi, other new Alzheimer’s drugs require better biomarkers

N.Y. state detects polio case, first in the U.S. since 2013

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

leisure time

hotspot

hotspot

hotspot